Kyle Fasulo joined F-Prime as a Finance Manager in January 2026. Prior to joining F-Prime, he worked at RSM in the Financial Due Diligence practice, where he supported transaction analysis and key financial assessments for a range of clients. Prior to that, he was part of KPMG’s Audit practice within the Alternative Investments group, focusing on venture capital funds, endowments and other private investment vehicles.
Kyle holds bachelor’s degrees in Finance and Accounting from Roger Williams University and a master’s degree in Accounting from Bryant University.
Nikhil is a Principal at F-Prime, where he spearheads the firm’s efforts in healthcare growth equity. His primary focus is to partner with rapidly growing, capital efficient businesses in healthcare software and services.
Prior to joining F-Prime, Nikhil worked at Juxtapose, a creation-oriented investment firm focused on healthcare and technology, where he spent 2 years incubating a new business venture in the pharmaceutical services ecosystem. Prior to Juxtapose, Nikhil spent 13 years at Silversmith Capital Partners and TA Associates, where he closed 12 growth-stage investments across healthcare and enterprise software. He began his career as a technology investment banker at Evercore.
Nikhil has a BS in Economics from The Wharton School at the University of Pennsylvania, with concentrations in Finance and Management.
Olivia Carlson is a Senior Associate at F-Prime, focusing on investments in healthcare technology and services companies. Prior to joining F-Prime, she was an investor at M33 Growth, where she assessed investment opportunities and supported their portfolio of growth-stage healthcare companies. Olivia also worked in strategy consulting for EY-Parthenon’s healthcare team. She started her career as a certified nursing assistant, working for a home health and hospice company throughout college.
Olivia holds a B.A. from Williams College, where she majored in Pre-Medical Studies and Psychology.
Chance is an Associate at F-Prime, where he focuses on early-stage investments in enterprise software. Before joining F-Prime, he was a consultant in Accenture’s Software & Platforms Strategy practice, advising leading hyperscalers and technology companies on go-to-market, product, and market expansion strategies.
Chance holds a B.S. in Managerial Economics from the University of California, Davis.
Crissy Derome joined F-Prime Capital in 2024 and currently supports the Crypto team. She also serves as Project Coordinator for Fine Structure Ventures, where she manages executive operations, complex scheduling, and cross-functional initiatives with precision and discretion.
Before joining F-Prime, Crissy held senior administrative roles at Fidelity Investments and Devonshire Investors, supporting executives across Corporate Development, Fidelity Labs, and Asset Management. Earlier in her career, she spent over a decade at Shields Health Care Group, leading administrative operations and coordinating major corporate and philanthropic events.
She holds a degree in Paralegal Studies from Eastern Nazarene College and is a certified Notary Public in the Commonwealth of Massachusetts.
Tomesha Campbell joined F-Prime in September 2025 as an Executive Assistant to Stacie Weninger, PhD and Chong Xu, PhD. Prior to joining F-Prime, she worked as an Administrative Assistant for Harvard Management Company, where she supported the finance, operations, and investment teams.
Tomesha earned her BA from Albright College and holds a dual MA from The Heller School at Brandeis University.
Tenzin Jampa joined F-Prime in 2025 as a data scientist, where he focuses on data science and automation. Tenzin graduated from MIT in 2025. During his time at MIT, he conducted research at the Laboratory for Nuclear Science, worked on analyzing the early data samples from the 2024 LHCb Run, and evaluated Large Language Models for physics domain specialization. Tenzin enjoys writing and occasionally publishes on his blog. In his free time, he loves to watch or play soccer, go on walks, play video games, or read.
Tenzin holds a B.S. degree from MIT in Physics and Philosophy.
Eric joined F-Prime in 2021 as a Venture Partner focused on executive leadership and go-to-market functions in technology and cybersecurity companies. Eric has founded and helped lead organizations from startup to $100 million plus revenue, including RiskRecon (acquired by Mastercard), Trusteer (acquired by IBM), Imprivata (IPO), and Centra Software (IPO).
Eric earned his undergraduate degree from Wharton School of University of Pennsylvania and his MBA from MIT Sloan School of Management.
Dr. Namandjé N. Bumpus joined F-Prime in 2025, where she serves as a strategic advisor on regulatory science, regulatory affairs, and policy, bringing deep expertise from her previous roles as FDA Principal Deputy Commissioner and Chief Scientist. Before the FDA, Dr. Bumpus was the E.K. Marshall and Thomas H. Maren Professor and director of the Department of Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine, where her research advanced understanding of drug metabolism, mechanisms of drug-induced toxicity, pharmacogenetics, bioanalytical chemistry, infectious disease pharmacology, and single cell biology. She completed her postdoctoral fellowship at The Scripps Research Institute and holds a PhD in pharmacology from the University of Michigan and a bachelor’s degree in biology from Occidental College.
Dr. Bumpus is a past-president of the American Society for Pharmacology and Experimental Therapeutics, a fellow of the American Association for the Advancement of Science, and a member of the National Academy of Medicine.
Claire Knowlton joined F-Prime in 2025 as a Marketing Associate. Claire supports marketing initiatives through event planning and internal communications. Previously, she worked at an estate planning law firm, focusing on email and social media marketing.
Claire holds a BA in Marketing from Loyola University Chicago.